Ftse Mib
33.280,87
0,16%
DAX
19.146,17
0,76%
S&P 500
5.943,27
0,44%
NASDAQ
18.914,54
-0,27%
Bitcoin
97.614,52
3,45%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSX Eupraxia Pharmaceuticals Inc (EPRX) Eupraxia Pharmaceuticals Inc (EPRX) Notizie

Eupraxia Pharmaceuticals Inc

EPRX
4,70
-0,33 (-6,56%)
Ultimo aggiornamento: 17:53:49
Dati in Delay di 15 minuti
Borsa: Toronto
Tipo: Azione
Valuta: CAD

Ultime notizie

Data Ora Fonte Titolo
20/11/202413:00PRNCAEupraxia's DiffuSphere™ Technology Demonstrates Targeted..
14/11/202423:00PRNUSEupraxia Pharmaceuticals to Present at American College of..
13/11/202423:00PRNCAEupraxia Pharmaceuticals' CEO Dr. James Helliwell to..
12/11/202423:56PRNUSEupraxia Pharmaceuticals Announces Positive Data from Fifth..
07/11/202423:00PRNUSEupraxia Pharmaceuticals Reports Third Quarter 2024..
01/11/202400:36PRNUSEupraxia Pharmaceuticals Announces that it has Closed a..
28/10/202412:00PRNUSEupraxia Pharmaceuticals to Present at American College of..
15/10/202413:00PRNUSLancet Rheumatology Publishes Phase 2b Data on Eupraxia..
10/10/202413:00PRNUSEupraxia Pharmaceuticals to Present at United European..
02/10/202423:01PRNCAEupraxia Pharmaceuticals Strengthens Senior Management Team
19/9/202423:00PRNCAEupraxia Pharmaceuticals to Present at 20th ISDE World..
11/9/202413:00PRNUSEupraxia Pharmaceuticals Announces Data from RESOLVE Phase..
04/9/202413:00PRNUSEupraxia Pharmaceuticals to Present at the H.C. Wainwright..
07/8/202423:00PRNUSEupraxia Pharmaceuticals Reports Second Quarter 2024..
02/8/202413:00PRNUSEupraxia Pharmaceuticals Announces New C$12 Million..
08/7/202413:00PRNUSEupraxia Pharmaceuticals to Present at Controlled Release..
03/7/202423:00PRNCAEupraxia Pharmaceuticals' CEO Dr. James Helliwell to..
06/6/202423:00PRNUSEupraxia Pharmaceuticals Announces Voting Results from..
05/6/202413:00PRNUSEupraxia Pharmaceuticals to Present Data from the Phase 2..
23/5/202423:00PRNUSEupraxia Pharmaceuticals Announces Expansion of RESOLVE..
22/5/202413:00PRNCAEupraxia Pharmaceuticals to Host Virtual KOL Event on..
21/5/202423:00PRNCAEupraxia Pharmaceuticals Announces New Positive Data from..
14/5/202413:00PRNUSEupraxia Pharmaceuticals to Present Initial Results from..
08/5/202423:03PRNUSEupraxia Pharmaceuticals Reports First Quarter 2024..
02/5/202413:00PRNUSEupraxia Pharmaceuticals Announces Gastrointestinal Clinical..
11/4/202413:00PRNUSEupraxia Pharmaceuticals Announces Upcoming Presentations at..
08/4/202413:00PRNUSEupraxia Pharmaceuticals To Present at Bloom Burton & Co...
05/4/202413:00PRNUSEupraxia Pharmaceuticals Begins Trading on Nasdaq Today
03/4/202423:00PRNCAEupraxia Pharmaceuticals to Begin Trading on Nasdaq on April..
01/4/202423:01PRNCAEupraxia Pharmaceuticals Reports Fourth Quarter and 2023..
15/3/202413:26GLOBEEupraxia Pharmaceuticals Announces Closing of Overnight..
12/3/202414:41PRNCAL'Organisme canadien de réglementation des investissements..
12/3/202414:39PRNCACanadian Investment Regulatory Organization Trade Resumption..
12/3/202414:31GLOBEEupraxia Pharmaceuticals Announces Pricing of Overnight..
11/3/202421:08GLOBEEupraxia Pharmaceuticals Announces Overnight Marketed..
11/3/202421:06PRNCASuspension de la négociation par l'Organisme canadien de..
11/3/202421:04PRNCACanadian Investment Regulatory Organization Trading Halt -..
05/2/202423:00PRNCAEupraxia Pharmaceuticals Announces Updated Positive Clinical..
01/2/202413:00PRNCAEupraxia Pharmaceuticals Initiates Phase 3 Development..
30/1/202413:00PRNCAEupraxia Pharmaceuticals Announces Positive Data from MRI..
09/1/202400:44PRNCAEupraxia Pharmaceuticals Announces Filing of Preliminary..
12/12/202313:00PRNCAEupraxia Pharmaceuticals Announces Positive Clinical Data in..
11/12/202313:00PRNCAEupraxia Pharmaceuticals Announces Clinical and Corporate..
Apertura: 4,85 Min: 4,57 Max: 5,04
Chiusura: 5,03

La tua Cronologia

TSX
EPRX
Eupraxia Pharmaceuticals
BIT
1BRE
Brenntag
BOV
IRBR3
IRB BRASIL ON
BMF
SOYH25
SOYH25 - Fevereiro 2025
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network